22.418 articles found

ANTIBODIES AND THEIR USE IN THE TREATMENT, PREVENTION AND DIAGNOSIS OF A DISEASE ASSOCIATED WITH SOD1 ABNORMALITIES

URUSHITANI MAKOTO, JULIEN JEAN-PIERRE.

· 2006-08-31

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease.

Lemieux S, Ghassemi M, Jog M, Edwards R, Duval C.

Exp Brain Res · 2006-08-30

DOI: 10.1007/s00221-006-0632-2PMID: 16944114

COMBINATION OF A NMDA RECEPTOR ANTAGONIST AND A MAO-INHIBITOR OR A GADPH-INHIBITOR FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM-RELATED CONDITIONS

WENT GREGORY T, MEYERSON LAWRENCE, FULTZ TIMOTHY J.

· 2006-08-28

Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade).

Sharma JC, Macnamara L, Hasoon M, Vassallo M, Ross I.

Parkinsonism Relat Disord · 2006-08-28

DOI: 10.1016/j.parkreldis.2006.07.002PMID: 16935018

USE OF PIPERAZINYL-2(3H)-BENZOXAZOLONE COMPOUNDS FOR THE PREPARATION OF AN IONTOPHORETIC DEVICE FOR THE TREATMENT OF PARKINSON'S DISEASE AND RESTLESS LEGS SYNDROME

Check source for author details

· 2006-08-24

Intravenous levodopa administration in humans based on a two-compartment kinetic model.

Gordon M, Markham J, Hartlein JM, Koller JM, Loftin S, Black KJ.

J Neurosci Methods · 2006-08-24

DOI: 10.1016/j.jneumeth.2006.07.010PMID: 16934332

Acute levodopa administration reduces cortisol release in patients with Parkinson's disease.

Müller T, Welnic J, Muhlack S.

J Neural Transm (Vienna) · 2006-08-24

DOI: 10.1007/s00702-006-0552-0PMID: 16932991

MUSCARINIC RECEPTOR ANTAGONISTS OR AGENTS FOR THE PREVENTION AND TREATMENT OF NERVOUS SYSTEM DISEASES BY ORGANOPHOSPHATE INTOXICATION CONTAINING 2-PHENYL-2-CARBOXYLIC ACID ESTER DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT

JUNG YOUNG SIK, PARK NO SANG, PARK WOO KYU, KONG JAE YANG.

· 2006-08-23

Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.

Meagher LJ, McKay D, Herkes GK, Needham M.

J Clin Neurosci · 2006-08-17

DOI: 10.1016/j.jocn.2005.09.017PMID: 16914315

Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.

Meco G, Bernardi S.

Prog Neuropsychopharmacol Biol Psychiatry · 2006-08-17

DOI: 10.1016/j.pnpbp.2006.06.016PMID: 16919377

USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE

LAMBIASE Alessandro, BONINI Stefano.

· 2006-08-11

USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE

LAMBIASE ALESSANDRO, BONINI STEFANO.

· 2006-08-11